For laboratory research use only - not for human consumption

Compound hub

Tesamorelin

Tesamorelin is a synthetic 44-amino-acid copy of growth-hormone-releasing hormone with a hexenoyl group at one end, and the FDA approved it in 2010 as Egrifta for excess abdominal fat in adults with HIV and lipodystrophy. This hub answers the questions people ask about it from FDA labels, published trials and regulator records.

Articles 4Updated 2026-10-14

Record card

Record card for Tesamorelin
Common nametesamorelin
Structure44-amino-acid human GRF sequence plus an N-terminal hexenoyl group (FDA Egrifta SV label, section 11)
US brand namesEgrifta SV and Egrifta WR (Theratechnologies Inc.)
US-approved useReduction of excess abdominal fat in HIV-infected adults with lipodystrophy; first approved 2010
Label half-life8 minutes (Egrifta SV) in healthy subjects
ARTG keyword search, 14 October 2026No matching results for 'tesamorelin' or 'Egrifta'
Poisons Standard statusHeld: stated on no page, in either direction
WADA 2026 Prohibited ListClass S2.2.4, prohibited at all times

Questions answered here

04
  1. Tesamorelin side effects: what the FDA label and trials reportTesamorelin side effects from the FDA Egrifta SV label and published trials: common events, warnings, heart, liver, hormones, what happened after stopping, and what is not known.Updated 2026-10-14
  2. What does tesamorelin do? What published studies foundWhat published studies found about tesamorelin: growth-hormone signalling, visceral fat, weight, muscle, fat returning after stopping, and what has not been tested.Updated 2026-10-14
  3. Tesamorelin vs sermorelin: what the records compareTesamorelin and sermorelin compared from FDA records and a 2026 review: structure, approvals, half-life, evidence tiers, hexarelin, steroids and why these records do not support a ranking.Updated 2026-10-14
  4. Is tesamorelin legal in Australia? ARTG, TGA, FDA and WADA recordsTesamorelin in Australia: the ARTG search result, the TGA's position, the FDA approval and label facts, and the WADA 2026 listing, each with its check date.Updated 2026-10-14

Form Laboratories supplies research-use-only reference material. Everything in this hub is an educational summary of published third-party literature. It is not medical advice, not a use instruction, and research material is not for human or animal use.

2026 Form Laboratories - Research use only - Perth WAPerth WA 6000 - current batch certification unverified, dispatched Australia-wide via Australia Post or CouriersPlease